News: PBT Prana Biotechnology Enters Securities Purchase Agreement With Life Biosciences LLC, page-19

Given the market crashing over the last few months, this funding gets rid of any time delays in securing finances for phase 2 drug development.

With Trumps unpredictability, financial stability and drug development continuity is a major milestone in this announcement. You only have to look at some other ASX bios to realise how crucial funding is when at all time lows.

Now we have a clear path forward and surety in moving onwards and upwards and is very important for anyone that remembers delays caused with last market crash.

Once phase 1 is finalised and phase 2 is announced, rerating is inevitable ( just depends what price point you want to jump in at right now).

Prana has a great story to tell and deliver on it, it just hasn’t been communicated well to this point IMO.